First human test of 'Off-the-Shelf' cell therapy for tough blood cancers
NCT ID NCT04984356
Summary
This study tested the safety and early effectiveness of a new type of cell therapy called WU-CART-007 in adults and adolescents with T-cell leukemia or lymphoma that has come back or not responded to other treatments. The main goals were to find a safe dose and see if the therapy could help control the cancer. It involved 28 patients who had no other standard treatment options available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
City of Hope
Duarte, California, 91010, United States
-
Erasmus MC
Rotterdam, Netherlands
-
Hospital Saint- Louis
Paris, France
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
-
Prinses Maxima Centrum
Utrecht, Netherlands
-
University Hospital Robert Debre
Paris, France
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Vanderbilt University
Nashville, Tennessee, 37212, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.